David Kang Halozyme Therapeutics

David Kang is Associate Director of Drug Delivery at Halozyme Therapeutics. He has been with Halozyme since 2008 and is a subject matter expert in recombinant human hyaluronidase facilitated rapid, large volume subcutaneous administration of biotherapeutics.

Prior to that, David spent over a decade between Pfizer and Schering-Plough researching oncology therapeutics and viral based gene delivery.

David is a graduate of the University of California at San Diego and started his research career at UCSD Medicine working on gene therapy approaches on infectious disease before transitioning to the bio-pharmaceutical industry.